Comparable stake leader
Gregory George
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001345099.
Comparable stake leader
Gregory George
Disclosed value leader
Gregory George
Comparable rows
50/50
Latest evidence
09 Apr 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Gregory George |
3/4/5
13D/G
Director, 10%+ Owner · George, Gregory
|
22%
from 13D/G
|
$2,762,560,264
166,358,342 shares
|
+$8,552,214 | 09 Apr 2026 |
| Gueck William J. |
13D/G
|
5%
|
$1,040,093,028
64,521,900 shares
|
$0 | 12 Sep 2025 |
| Silviu Itescu |
3/4/5
CEO and Managing Director, Director
|
6.1%
|
$1,424,419,060
78,958,928 shares
|
— | 18 Mar 2026 |
| Eric Allen Rose |
3/4/5
Chief Medical Officer,Director, Director
|
0.06%
|
$12,093,062
714,720 shares
|
— | 18 Mar 2026 |
| Jane Catherine Bell |
3/4/5
Director
|
0.05%
|
$10,532,564
622,492 shares
|
— | 18 Mar 2026 |
| Philip R. Krause |
3/4/5
Director
|
0.02%
|
$4,864,500
287,500 shares
|
— | 18 Mar 2026 |
| William Murray Burns |
3/4/5
Director
|
0.02%
|
$4,081,550
226,250 shares
|
— | 18 Mar 2026 |
| Philip James Facchina |
3/4/5
Director
|
0.01%
|
$2,084,882
123,220 shares
|
— | 18 Mar 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to buying over the last 12 months. Net value: +$8,552,214.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 595,000 | 0 | $8,552,214 | $0 | +$8,552,214 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-9 of 9 reporting-owner rows connected to MESOBLAST LTD. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Gregory George | Director, 10%+ Owner | $2,762,560,264 | +$8,552,214 | +0.31% | Mixed | 09 Apr 2026 |
| Silviu Itescu | CEO and Managing Director, Director | $1,424,419,060 | Mixed | 18 Mar 2026 | ||
| Eric Allen Rose | Chief Medical Officer,Director, Director | $12,093,062 | Mixed | 18 Mar 2026 | ||
| Jane Catherine Bell | Director | $10,532,564 | Mixed | 18 Mar 2026 | ||
| Philip R. Krause | Director | $4,864,500 | Mixed | 18 Mar 2026 | ||
| William Murray Burns | Director | $4,081,550 | Mixed | 18 Mar 2026 | ||
| Philip James Facchina | Director | $2,084,882 | Mixed | 18 Mar 2026 | ||
| Lynette Elizabeth Cobley | Director | $905,310 | Mixed | 18 Mar 2026 | ||
| James Michael O'Brien | Chief Financial Officer | Mixed | 18 Mar 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Gregory George | MESO | Ordinary Shares | Purchase | 38.7% | 2,324,072 | 8,324,072 | 10 Apr 2026 | Held by Grant George, who has granted power of attorney to Dr. George. | ||
| Gregory George | MESO | Ordinary Shares | Purchase | 38.7% | 2,324,072 | 8,324,072 | 10 Apr 2026 | Held by Grant George, who has granted power of attorney to Dr. George. | ||
| Gregory George | MESO | Ordinary Shares | Purchase | 13.2% | 1,586,890 | 13,586,890 | 09 Apr 2026 | As above. | ||
| Gregory George | MESO | Ordinary Shares | Purchase | 4.58% | $8,552,214 | $14.37 | 595,000 | 13,586,890 | 09 Apr 2026 | As above. |
| Gregory George | MESO | Ordinary Shares | Purchase | 7.39% | 886,890 | 12,886,890 | 09 Apr 2026 | As above. | ||
| Gregory George | MESO | Ordinary Shares | Purchase | 50% | 4,000,000 | 12,000,000 | 04 Apr 2026 | Held by James George, who has granted power of attorney to Dr. George. | ||
| Gregory George | MESO | Ordinary Shares | Purchase | 50% | 4,000,000 | 12,000,000 | 04 Apr 2026 | Held by James George, who has granted power of attorney to Dr. George. |